{"id":"W4379376555","doi":"10.1182/bloodadvances.2023010179","title":"Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Astellas Pharma; Daiichi Sankyo Europe; Agios Pharmaceuticals; Celgene; Gilead Sciences; Astex Pharmaceuticals; Daiichi-Sankyo; Pfizer; Amgen","keywords":"Internal medicine; Neutropenia; Medicine; Hazard ratio; Febrile neutropenia; Gastroenterology; Cytarabine; Population; Confidence interval; Leukemia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000832954,0.0005047238,0.001715325,0.0003935593,0.0001346311,0.00005592106,0.0003389323,0.0001453203,0.000118993],"category_scores_gemma":[0.001351956,0.0003706332,0.000309563,0.002180012,0.0002242913,0.0003385347,0.0001691568,0.0003640657,0.0003046732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001326283,"about_ca_system_score_gemma":0.0008184566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001313706,"about_ca_topic_score_gemma":0.001300528,"domain_scores_codex":[0.9961251,0.00038364,0.0008193106,0.0008793265,0.0008217021,0.0009709055],"domain_scores_gemma":[0.9972552,0.001356785,0.0001692962,0.0007125771,0.0001291657,0.0003769421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3645728,0.02418634,0.3175896,0.0003894169,0.007617452,0.0436538,0.005009795,0.0007560547,0.007660076,0.0002518784,0.004844276,0.2234684],"study_design_scores_gemma":[0.950142,0.004802017,0.02535638,0.0001389709,0.001407671,0.0001280216,0.00128484,0.0009988402,0.001698369,0.0001606825,0.01343985,0.0004423107],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881125,0.002807525,0.0000253517,0.002083576,0.000238636,0.004882157,0.0001049942,0.0004016415,0.001343614],"genre_scores_gemma":[0.9873259,0.005428368,0.0008958894,0.000329293,0.0005423772,0.002092544,0.0001932656,0.00006817265,0.0031242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5855692,"threshold_uncertainty_score":0.9998745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02117231845214376,"score_gpt":0.3626140387781905,"score_spread":0.3414417203260468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}